Echo Therapeutics, Inc.
| Nasdaq: ECTE
Echo Therapeutics, Inc. is a transdermal medical device company with significant expertise in advanced skin permeation technology. It develops Prelude SkinPrep System as a platform technology to allow for painless and significantly enhanced skin permeation that will enable both needle-free drug delivery and analyte extraction. The company was founded on September 14, 2007 and is headquartered in Philadelphia, PA.